State Street Corp Lineage Cell Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,608,352 shares of LCTX stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,608,352

Previous 2,562,869 1.77%

Holding current value

$1.46 Million

Previous $2.56 Million 7.38%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.8 - $1.12 $36,386 - $50,940	45,483 Added 1.77%	2,608,352 $2.37 Million
Q2 2024 Aug 14, 2024	BUY	$0.89 - $1.47 $343,237 - $566,920	385,660 Added 17.71%	2,562,869 $2.56 Million
Q1 2024 May 15, 2024	BUY	$0.86 - $1.48 $69,316 - $119,288	80,600 Added 3.84%	2,177,209 $3.22 Million
Q4 2023 Feb 14, 2024	BUY	$0.91 - $1.35 $67,124 - $99,580	73,763 Added 3.65%	2,096,609 $2.29 Million
Q3 2023 Nov 14, 2023	BUY	$1.16 - $1.53 $97,595 - $128,725	84,134 Added 4.34%	2,022,846 $2.39 Million
Q2 2023 Aug 14, 2023	BUY	$1.26 - $1.53 $1.89 Million - $2.3 Million	1,501,216 Added 343.14%	1,938,712 $2.73 Million
Q4 2022 Feb 14, 2023	SELL	$1.02 - $1.5 $2,652 - $3,900	-2,600 Reduced 0.59%	437,496 $511,000
Q2 2022 Aug 15, 2022	SELL	$1.12 - $1.61 $1.86 Million - $2.68 Million	-1,665,011 Reduced 79.09%	440,096 $695,000
Q1 2022 May 16, 2022	BUY	$1.21 - $2.48 $37,356 - $76,565	30,873 Added 1.49%	2,105,107 $3.24 Million
Q4 2021 Feb 14, 2022	SELL	$1.84 - $2.68 $6.23 Million - $9.07 Million	-3,384,217 Reduced 62.0%	2,074,234 $5.08 Million
Q3 2021 Nov 15, 2021	BUY	$2.26 - $2.86 $8.11 Million - $10.3 Million	3,590,405 Added 192.2%	5,458,451 $13.8 Million
Q2 2021 Aug 16, 2021	BUY	$2.17 - $3.0 $3.91 Million - $5.41 Million	1,802,392 Added 2745.29%	1,868,046 $5.32 Million
Q1 2021 May 17, 2021	BUY	$1.77 - $3.1 $13,275 - $23,250	7,500 Added 12.9%	65,654 $154,000
Q2 2020 Aug 14, 2020	SELL	$0.71 - $1.18 $1.2 Million - $2 Million	-1,695,837 Reduced 96.68%	58,154 $51,000
Q1 2020 May 11, 2020	BUY	$0.6 - $1.58 $1.05 Million - $2.77 Million	1,753,991 New	1,753,991 $1.45 Million

Others Institutions Holding LCTX

# of Institutions

120

Shares Held

94.2M

Call Options Held

63.8K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $95.1M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Lineage Cell Therapeutics, Inc. Transaction History